Clinical Evaluation of Surrounding Electroacupuncture in the Treatment of Acute Lateral Ankle Sprain

Comparison and evaluation of the difference in clinical efficacy of electroacupuncture combined with surrounding acupuncture and sham electroacupuncture groups and control group (ice compress combined with brake rest group) in the treatment of ALAS by means of musculoskeletal ultrasound technique.

Study Overview

Detailed Description

  1. To evaluate the efficacy and safety of electroacupuncture combined with surrounding acupuncture in the treatment of ALAS,and compare its differences and advantages with traditional therapy.
  2. To investigate the effect of electroacupuncture combined with surrounding acupuncture on the physiological and biochemical changes of the affected nerve,muscle and ligament, as well as its mechanism and pathway.
  3. To investigate the influence of treatment time,frequency,intensity,stimulation point and other factors on the therapeutic effect and mechanism,further optimize the treatment plan and improve the therapeutic effect and efficiency.
  4. To demonstrate the unique advantages and value of acupuncture analgesia,strengthen the concept and practice of integrated Chinese and Western medicine,and make contributions to promoting the application and development of acupuncture analgesia in the field of orthopedics and traumatology.

Study Type

Interventional

Enrollment (Estimated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310000
        • Recruiting
        • The Third Affiliated hospital of Zhejiang Chinese Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Meets the diagnostic criteria for a grade I or II injury;
  • Onset time≤48h;
  • The patient aged between18 and 60, gender is not limited;
  • The skin of the ankle joint on the affected side is intact, without breakage or ulceration;

Exclusion Criteria:

  • Combined with ankle fracture;
  • Grade III injury or complete ligament rupture;
  • Those who cannot comply with the treatment program. Those with keloid, localized combination of other skin diseases, and those who are not suitable for electroacupuncture treatment;
  • Those with serious cardiovascular, cerebrovascular, hepatic, renal, hematopoietic system or systemic failure, connective tissue disease, hemophilia, diabetes mellitus, malignant tumors, and those who are prone to bleeding tendency.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: electroacupuncture group
electroacupuncture combined with surrounding acupuncture
electroacupuncture combined with surrounding acupuncture
Sham Comparator: sham electroacupuncture group
sham electroacupuncture
sham electroacupuncture
Placebo Comparator: ice compress combined with brake rest group
ice compress combined with brake rest
ice compress combined with brake rest

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kofoed
Time Frame: before treatment(baseline,week0), after treatment(week4) and 1 week after treatment(follow-up,week5).
The Kofoed evaluation system was divided into 3 items, which were evaluated before treatment, 3 weeks after treatment and after treatment. The ankle joint function was evaluated mainly from three aspects of pain, function and range of motion, with a total score of 100.
before treatment(baseline,week0), after treatment(week4) and 1 week after treatment(follow-up,week5).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
musculoskeletal ultrasound quantitative measurement
Time Frame: before(baseline,week0)and after treatment(week4).
The thickness of lateral collateral ligament of ankle joint was measured by GE LOGIQ-e portable color Doppler ultrasonography before and after treatment. The frequency of linear array probe was 8 ~ 12 mHz.
before(baseline,week0)and after treatment(week4).
circumference of ankle joint
Time Frame: before treatment(baseline,week0), after treatment(week4) and 1 week after treatment(follow-up,week5).
The circumference of ankle joint was measured in 3 groups before, 3 weeks and after treatment.
before treatment(baseline,week0), after treatment(week4) and 1 week after treatment(follow-up,week5).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Xianming Lin, Phd, The Third Affiliated hospital of Zhejiang Chinese Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 23, 2023

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

November 22, 2026

Study Registration Dates

First Submitted

December 1, 2023

First Submitted That Met QC Criteria

December 13, 2023

First Posted (Estimated)

December 27, 2023

Study Record Updates

Last Update Posted (Estimated)

December 27, 2023

Last Update Submitted That Met QC Criteria

December 13, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ZSLL-ZN-2023-011-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Electroacupuncture

Clinical Trials on electroacupuncture combined with surrounding acupuncture

Subscribe